Browsing Tag
FTSE 250
52 posts
XPS Pensions (LSE: XPS) revenue rises 13% as insurance consulting expands growth opportunity
XPS Pensions reports 13% revenue growth and a higher dividend, but XPS shares fall as investors assess margins, Polaris costs and insurance expansion.
Ithaca Energy slides despite strong Q1 as ITH loses Middle East oil-risk premium
Find out how Ithaca Energy’s share price fall, oil price reversal and dividend outlook are reshaping ITH stock and North Sea sentiment.
Wizz Air FY26 results expose recovery tension as WIZZ stock jumps despite thin profit
Find out how Wizz Air’s record passengers, engine recovery and Iran war uncertainty are reshaping WIZZ stock and Europe’s low-cost airline race.
Tate & Lyle is leaving London after 87 years, but is the Ingredion premium enough?
Tate & Lyle agreed a £2.7bn Ingredion takeover. Find out what the $TATE deal means for investors and London’s market.
Can Drax Group turn Bluefield Solar Income Fund into a post-biomass growth engine?
Drax is buying renewables scale. The harder question is whether Bluefield Solar can offset biomass risk and reset investor confidence.
GB Group (LSE: GBG) stock slides as FY26 results expose the cost of its AI identity platform reset
GB Group plc is betting on GBG Go after FY26 results, but investors are watching margins and debt. Find out what comes next.
Ocado Group (OCDO) stock jumps as Asda ecommerce deal gives UK grocery tech model a fresh test
Ocado Group plc has won a major Asda ecommerce deal. Find out why the partnership could reshape UK online grocery and OCDO sentiment today!
Why Apollo’s Bodycote proposal is another warning sign for UK industrial stocks
Apollo’s Bodycote proposal exposes the UK industrial valuation gap. Read why private equity is circling London-listed specialists.
Spire Healthcare (LSE: SPI) takeover talks: Why Toscafund’s 250p bid could reshape the UK private hospital investment case
Spire Healthcare found a buyer before the market found conviction. Toscafund’s 250p approach now tests UK healthcare valuation logic.
GB Group plc (LSE: GBG) says FY26 was in line, so why does the update still matter for investors?
GB Group plc says FY26 was in line as growth accelerated in H2. Read what GBG’s platform push, buybacks, and FY27 outlook could mean next.